As the number of blockchain protocols and platforms has increased significantly over the past 3 years, it can be challenging for enterprises to identify the best for building their blockchain-enabled solutions. As an early-stage B2B SaaS company, Triall matched with a public blockchain platform that offers an enterprise-grade infrastructure, substantiated by a track record of […]
As 2019 comes to an end, the holiday season provides us with time to reflect on what has happened in the past year. It has been an exciting year for Triall, in which we initiated use of our first application, published our whitepaper, and expanded our global value network of partners and advisors. In this […]
In part 1 and part 2 of this series, we explained how blockchain technology can be leveraged to enhance the integrity, auditability, and exchange of data in clinical trials. In this article, we will cover how smart contracts can be used to automate clinical trial activities and improve protocol compliance. This is the final article of a three-part series […]
In part 1 of this series, we explained how blockchain technology can be leveraged to enhance data integrity, auditability, and traceability in clinical trials. In this article, we dive into other unique opportunities offered by blockchain, focusing specifically on Decentralized Identifiers. This article is the second in a three-part series on blockchain in clinical trials, and was […]
Allan Bukuya has joined the Triall initiative as Advisor eClinical Solutions. He brings two decades of experience in clinical research and in-depth understanding of the Pharma, CRO and eClinical industries. Allan is the founder of TrialDocs, a clinical trial services company that offers eClinical solutions for document management to clinical trial sites, empowering researchers to better […]
In a previous article, we introduced clinical trials and explained why they are so important to our health systems. In this article, we will address how blockchain technology can play a fundamental role in tackling some of the persisting issues that make today’s clinical trials overly complex, lengthy and resource-inefficient. This article is the first in […]
Danielle Bradbury will join the Triall initiative as advisor Quality and Compliance. She has over 20 years of experience in clinical research and has extensive knowledge of SOP management, GxP inspection readiness, computer system validation, and quality compliance. Danielle currently is Head of Quality Assurance at Galera Therapeutics where she provides senior strategic quality leadership ensuring […]
Sina Djali will join the ranks of the Triall initiative as advisor Clinical Trial Data Analytics. Sina has over 25 years of experience in drug and clinical development in various companies and academia. Sina Djali currently is the Head of Integrated Clinical and Operational Analytics in Enabling Business and Information Solutions at Janssen (a pharmacuetical […]
We are excited to announce the world’s first clinical trial on the blockchain. A beta version of the foundation’s Verial software application was given green light for use in a real-world clinical trial and is now live in production, following positive assessment of its compliance with international regulations and quality standards for medical research. This marks […]
A steady and efficient influx of novel medical solutions is critical for meeting society’s current and future medical needs. The clinical research industry is responsible for the delivery of these solutions to society by systematically evaluating their safety and efficacy in so-called clinical trials. But what do clinical trials exactly entail and why are they […]